Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Newamsterdam Pharma Company N.V. (NAMS)

Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Newamsterdam Pharma Company N.V. GOOIMEER 2-35 NARRDEN P7 1411 DC NLD

www.newamsterdampharma.com Employees: 68 P: 35-206-2971

Sector:

Medical

Description:

NewAmsterdam Pharma Holding B.V. is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. NewAmsterdam Pharma Holding B.V., formerly known as Frazier Lifesciences Acquisition Corporation, is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 4,223,815
Enterprise Value, $K 3,452,075
Shares Outstanding, K 113,391
Annual Sales, $ 45,560 K
Annual Net Income, $ -241,600 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -72,010 K
EBIT, $ -202,940 K
EBITDA, $ -202,830 K
60-Month Beta 0.05
% of Insider Shareholders 20.84%
% of Institutional Shareholders 89.89%
Float, K 89,760
% Float 79.16%
Short Volume Ratio 0.59

Growth:

1-Year Return 43.18%
3-Year Return 212.83%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 11/05/25
Next Earnings Date 02/25/26
Earnings Per Share ttm -2.00
EPS Growth vs. Prev Qtr -173.33%
EPS Growth vs. Prev Year -127.78%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NAMS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.29%
Return-on-Assets % -26.20%
Profit Margin % -530.29%
Debt/Equity 0.00
Price/Sales 90.01
Price/Cash Flow N/A
Price/Book 5.62
Book Value/Share 6.43
Interest Coverage -2.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar